Trustmark National Bank Trust Department Astrazeneca PLC Transaction History

Trustmark National Bank Trust Department

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $15,247 - $17,047	-409 Closed	0 $0
Q3 2018 Feb 22, 2019	SELL	$34.76 - $39.72 $27,564 - $31,497	-793 Reduced 65.97%	409 $16,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $41,781 - $47,743	1,202 New	1,202 $48,000
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $362,947 - $389,210	-10,505 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $115,395 - $128,205	-3,500 Reduced 24.99%	10,505 $367,000

Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $6,161 - $6,677	-192 Reduced 1.35%	14,005 $486,000
Q3 2017 Nov 09, 2017	BUY	$28.96 - $34.0 $411,145 - $482,698	14,197	14,197 $481,000

1,248

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

Stay updated on Trustmark National Bank Trust Department with notifications on news.